CRL vs MH · rev $2.00B vs P/E 55, rev $2.10B
Charles River Laboratories (CRL) versus McGraw Hill, Inc. (MH) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
McGraw Hill, Inc. (MH) is a education & training services company listed on NYSE.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported MH revenue for 2026-03-31 was $2.10B. Net income was $35.3M. Revenue was up 0.1% from 2025-03-31 to 2026-03-31. MH currently screens at market cap $2.00B and trailing P/E 55.0.
CRL currently screens at market cap $7.78B. MH currently screens at market cap $2.00B and trailing P/E 55.0.
Not investment advice. Open the CRL and MH stock pages for the full models.
Not investment advice.